Johnson and Johnson’s COVID-19 Vaccine Should Be Reviewed by FDA Soon
By
In FDA & FTC Law
Posted

Johnson and Johnson’s COVID-19 Vaccine Should Be Reviewed by FDA Soon

Johnson & Johnson’s adenovirus-based vaccine for preventing the transmission of COVID-19 is expected to be reviewed by the Food and Drug Administration in February 2021.

READ MORE